The Elastomeric Infusion Pumps Market is segmented by Application (Pain management, Antibiotic or antiviral, Chemotherapy, and Others), End-user (Hospitals, Ambulatory service centers, Clinics, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW)). As per the Global Forecast research report 2024-2028 published by Technavio, the market size is estimated to grow by USD 813.9 million, at a CAGR of 6.78% during the forecast period. There are several companies that are contributing to the market as per this report. High demand for advanced infusion pumps .
In the realm of pain management, elastomeric infusion pumps have emerged as a preferred solution in the global market. These advanced medical devices are renowned for their utility in delivering controlled dosages of medication to patients over extended periods, making them an indispensable tool for pain relief therapy. The primary advantage of elastomeric infusion pumps lies in their ability to provide continuous, consistent pain relief. Engineered to dispense medication at a predetermined rate, these pumps ensure a steady flow of medication into the patient's body, thereby maintaining optimal pain control levels. Their ease of use, portability, and cost-effectiveness further augment their appeal, setting them apart from traditional infusion pumps.
For insights on company offerings- Request a sample report!
The Elastomeric Infusion Pumps market represents a significant business opportunity for healthcare technology providers. These pumps, which deliver medication through elastomeric membranes, ensure precise dosage and improved patient comfort. Market growth is driven by factors such as increasing chronic disease prevalence, rising healthcare expenditures, and technological advancements. Key players in this market include B. Braun Melsungen AG, Fresenius Kabi AG, and Hospira Worldwide, Inc.
To access the valuable insights - Download the Free Sample Report
Title: Elastomeric Infusion Pumps in Healthcare: A Viable Alternative to Syringe Drivers in Diabetes, Cardiovascular Diseases, and Oncology The International Diabetes Federation reports that diabetes and cardiovascular diseases are major health concerns worldwide. Elastomeric infusion pumps have emerged as a viable alternative to syringe drivers in administering medications for various conditions, including heart failure, diabetes, surgical procedures, antibiotic therapy, analgesia, chemotherapy, and palliative care. In cardiovascular diseases, elastomeric pumps are used for administering medications in intensive care units, reducing the disruption caused by frequent interventions. Diabetes patients benefit from these pumps for insulin delivery, ensuring consistent blood sugar levels. In oncology, elastomeric infusions are used for chemotherapy regimens like FOLFIRINOX and FOLFIRI for pancreatic cancers and colorectal cancer. They offer advantages over syringe drivers, such as longer infusion times and fewer interventions. However, limitations include the need for manual refills and potential for accidental overdoses. This article explores the role of elastomeric infusion pumps in managing heart failure, diabetes, and oncology treatments, focusing on their benefits, limitations, and applications in various therapeutic areas.
According to Technavio, the Elastomeric Infusion Pumps Market is a significant segment within the expansive Global Healthcare Equipment Market. This market encompasses organizations involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, implants, accessories, and consumables. These products are utilized for the diagnosis, monitoring, and treatment of numerous diseases. Technavio determines the size of the Global Healthcare Equipment Market by aggregating the revenues generated by manufacturers of diagnostic equipment and devices spanning diverse therapy areas. The healthcare equipment sector is segmented into Devices, which incorporates advanced, differentiated, and clinically validated data-driven devices. - The Elastomeric Infusion Pumps Market is experiencing significant growth, fueled by the . Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
